Saltar al contenido
Merck
  • 4,5-Disubstituted cis-pyrrolidinones as inhibitors of type II 17beta-hydroxysteroid dehydrogenase. Part 3. Identification of lead candidate.

4,5-Disubstituted cis-pyrrolidinones as inhibitors of type II 17beta-hydroxysteroid dehydrogenase. Part 3. Identification of lead candidate.

Bioorganic & medicinal chemistry letters (2006-06-30)
Jill Wood, Cedo M Bagi, Christiana Akuche, Antonietta Bacchiocchi, Jeremy Baryza, Marie-Luise Blue, Catherine Brennan, Ann-Marie Campbell, Soongyu Choi, James H Cook, Patricia Conrad, Brian R Dixon, Paul P Ehrlich, Todd Gane, David Gunn, Ted Joe, Jeffrey S Johnson, Jerold Jordan, Richard Kramss, Peiying Liu, Joan Levy, Derek B Lowe, Ian McAlexander, Reina Natero, Anikó M Redman, William J Scott, Christopher Town, Ming Wang, Yamin Wang, Zhonghua Zhang
RESUMEN

A series of 4,5-disubstituted cis-pyrrolidinones was investigated as inhibitors of 17beta-HSD II for the treatment of osteoporosis. Biochemical data for several compounds are given. Compound 42 was selected as the lead candidate.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
Phenylpropiolic acid, 99%